Variant report

Variant	nsv831529
Chromosome Location	chr9:24495736-24635767
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr9:24498551-24498891	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr9:24498268-24498396	H1-hESC	embryonic stem cell:	n/a	n/a
3	BRCA1	chr9:24608414-24608450	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr9:24601476-24601834	IMR90	lung:	n/a	chr9:24601658-24601669 chr9:24601659-24601670
5	CEBPB	chr9:24601485-24601846	A549	lung:	n/a	chr9:24601658-24601669 chr9:24601659-24601670
6	CEBPB	chr9:24601485-24601836	HepG2	liver:	n/a	chr9:24601658-24601669 chr9:24601659-24601670
7	CEBPB	chr9:24582769-24583084	HepG2	liver:	n/a	chr9:24582926-24582935 chr9:24582926-24582935 chr9:24582924-24582937 chr9:24582926-24582935 chr9:24582925-24582936 chr9:24582924-24582935 chr9:24582926-24582935
8	CEBPB	chr9:24556226-24556465	HepG2	liver:	n/a	chr9:24556345-24556356
9	CEBPB	chr9:24504513-24504726	HepG2	liver:	n/a	chr9:24504579-24504590 chr9:24504578-24504591 chr9:24504578-24504591 chr9:24504578-24504589 chr9:24504578-24504589
10	CEBPB	chr9:24542908-24543131	HepG2	liver:	n/a	chr9:24542993-24543004
11	CEBPB	chr9:24562320-24562452	A549	lung:	n/a	n/a
12	CEBPB	chr9:24573070-24573358	A549	lung:	n/a	chr9:24573224-24573235
13	CEBPB	chr9:24601522-24601759	Hela-S3	cervix:	n/a	chr9:24601658-24601669 chr9:24601659-24601670
14	CEBPB	chr9:24635554-24635668	A549	lung:	n/a	n/a
15	CEBPB	chr9:24505440-24505728	HepG2	liver:	n/a	chr9:24505566-24505577
16	CEBPB	chr9:24565572-24565772	A549	lung:	n/a	n/a
17	CEBPB	chr9:24556332-24556354	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr9:24573116-24573355	HepG2	liver:	n/a	chr9:24573224-24573235
19	CTCF	chr9:24616940-24617090	HEEpiC	esophagus:	n/a	n/a
20	CTCF	chr9:24614180-24614330	HA-sp	spinal cord:	n/a	chr9:24614271-24614279
21	CTCF	chr9:24614140-24614290	HCPEpiC	choroid plexus:	n/a	chr9:24614271-24614279
22	CTCF	chr9:24617020-24617096	LNCaP	prostate:	n/a	n/a
23	CTCF	chr9:24614160-24614310	SAEC	small airway:	n/a	chr9:24614271-24614279
24	CTCF	chr9:24614100-24614250	HAc	cerebellar:	n/a	n/a
25	CTCF	chr9:24614180-24614330	NHDF-neo	bronchial:	n/a	chr9:24614271-24614279
26	CTCF	chr9:24614179-24614356	Gliobla	brain:	n/a	chr9:24614271-24614279
27	CTCF	chr9:24614160-24614310	RPTEC	kidney:	n/a	chr9:24614271-24614279
28	CTCF	chr9:24614180-24614330	NHEK	skin:	n/a	chr9:24614271-24614279
29	CTCF	chr9:24614160-24614310	HRPEpiC	eye:	n/a	chr9:24614271-24614279
30	CTCF	chr9:24617009-24617011	Pancreas_OC	pancreas:	n/a	n/a
31	CTCF	chr9:24616949-24617112	NHEK	skin:	n/a	n/a
32	CTCF	chr9:24617000-24617150	RPTEC	kidney:	n/a	n/a
33	CTCF	chr9:24614180-24614330	BE2_C	brain:	n/a	chr9:24614271-24614279
34	CTCF	chr9:24614220-24614370	HA-sp	spinal cord:	n/a	chr9:24614271-24614279
35	CTCF	chr9:24613951-24614483	SK-N-SH	brain:	n/a	chr9:24614271-24614279
36	CTCF	chr9:24614160-24614310	HEEpiC	esophagus:	n/a	chr9:24614271-24614279
37	CTCF	chr9:24616920-24617070	WERI-Rb-1	eye:	n/a	n/a
38	CTCF	chr9:24616992-24617136	LNCaP	prostate:	n/a	n/a
39	CTCF	chr9:24614220-24614370	BE2_C	brain:	n/a	chr9:24614271-24614279
40	CTCF	chr9:24614177-24614370	LNCaP	prostate:	n/a	chr9:24614271-24614279
41	CTCF	chr9:24614160-24614310	AoAF	blood vessel:	n/a	chr9:24614271-24614279
42	CTCF	chr9:24616993-24617074	Gliobla	brain:	n/a	n/a
43	CTCF	chr9:24614180-24614330	HMEC	breast:	n/a	chr9:24614271-24614279
44	CTCF	chr9:24614203-24614328	MCF-7	breast:	n/a	chr9:24614271-24614279
45	CTCF	chr9:24614180-24614330	HEK293	kidney:	n/a	chr9:24614271-24614279
46	CTCF	chr9:24614180-24614330	WERI-Rb-1	eye:	n/a	chr9:24614271-24614279
47	CTCF	chr9:24614220-24614370	RPTEC	kidney:	n/a	chr9:24614271-24614279
48	CTCF	chr9:24614240-24614390	HEEpiC	esophagus:	n/a	chr9:24614271-24614279
49	CTCF	chr9:24616940-24617090	AoAF	blood vessel:	n/a	n/a
50	CTCF	chr9:24614240-24614390	HRE	kidney:	n/a	chr9:24614271-24614279

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:24613953..24614528-chr9:25350122..25350850,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DMRTA1-7	chr9:24561754-24561848	XLOC_007304
2	lnc-DMRTA1-7	chr9:24561325-24561428	XLOC_007304
3	lnc-DMRTA1-7	chr9:24561754-24561848	ENSG00000269957.1
4	lnc-DMRTA1-7	chr9:24561754-24561848	XLOC_007304
5	lnc-DMRTA1-7	chr9:24590269-24590449	ENSG00000269957.1
6	lnc-DMRTA1-7	chr9:24591877-24591991	ENSG00000269957.1
7	lnc-DMRTA1-7	chr9:24545422-24546127	XLOC_007304
8	lnc-DMRTA1-7	chr9:24591877-24592081	XLOC_007304
9	lnc-DMRTA1-7	chr9:24551961-24552127	ENSG00000269957.1
10	lnc-DMRTA1-7	chr9:24590269-24590449	XLOC_007304
11	lnc-DMRTA1-7	chr9:24590269-24590449	XLOC_007304
12	lnc-DMRTA1-7	chr9:24561754-24561848	XLOC_007304
13	lnc-DMRTA1-7	chr9:24591877-24592305	XLOC_007304
14	lnc-DMRTA1-7	chr9:24545400-24545526	XLOC_007304
15	lnc-DMRTA1-7	chr9:24545856-24546127	XLOC_007304
16	lnc-DMRTA1-7	chr9:24545996-24546127	ENSG00000269957.1
17	lnc-DMRTA1-7	chr9:24545423-24545526	XLOC_007304
18	lnc-DMRTA1-7	chr9:24545422-24546127	XLOC_007304
19	lnc-DMRTA1-7	chr9:24551961-24552127	XLOC_007304
20	lnc-DMRTA1-7	chr9:24590269-24590449	XLOC_007304
21	lnc-DMRTA1-7	chr9:24552919-24553082	XLOC_007304
22	lnc-DMRTA1-7	chr9:24591877-24592081	XLOC_007304
23	lnc-DMRTA1-7	chr9:24551961-24552127	ENSG00000269957.1
24	lnc-DMRTA1-7	chr9:24552919-24553237	ENSG00000269957.1
25	lnc-DMRTA1-7	chr9:24545856-24546127	XLOC_007304
26	lnc-DMRTA1-7	chr9:24551961-24552156	XLOC_007304
27	lnc-DMRTA1-7	chr9:24545950-24546127	ENSG00000269957.1

Variant related genes	Relation type
IZUMO3	TF binding region
ENSG00000269957	TF binding region
MAP3K4	miRNA target sites
ZDHHC17	miRNA target sites
MAP3K3	miRNA target sites
LEPROTL1	miRNA target sites
MAP3K7	miRNA target sites
FRS2	miRNA target sites

Extended variants
information (count: 3069 )
Associated
traits (count: 148 )

Variant overlapped rSNPs/rCNVs (count:3069 , 50 per page) page: 1 2 3 4 5 6 7 ... 62

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185740203	chr9:24495802-24495803	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs539642028	chr9:24495835-24495836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs552092616	chr9:24495850-24495851	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs566835803	chr9:24495860-24495861	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs77015377	chr9:24495862-24495863	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs534178811	chr9:24495898-24495899	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs534596944	chr9:24495912-24495913	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs560329983	chr9:24495928-24495929	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs529264135	chr9:24495989-24495990	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs549531402	chr9:24496020-24496021	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs569335966	chr9:24496044-24496045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs189214619	chr9:24496058-24496059	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs551564769	chr9:24496104-24496105	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs571412899	chr9:24496147-24496148	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs533890783	chr9:24496216-24496217	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs554014776	chr9:24496230-24496231	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs149648106	chr9:24496246-24496247	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs144382438	chr9:24496271-24496272	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs368673556	chr9:24496302-24496303	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs181558936	chr9:24496305-24496306	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs575685422	chr9:24496306-24496307	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs371071337	chr9:24496316-24496317	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs544411195	chr9:24496339-24496340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs557970364	chr9:24496408-24496409	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs57810397	chr9:24496472-24496473	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs540596294	chr9:24496484-24496485	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs35986347	chr9:24496576-24496577	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs573667216	chr9:24496713-24496714	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs560822366	chr9:24496727-24496728	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs538368560	chr9:24496772-24496773	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs529284544	chr9:24496780-24496781	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs185705391	chr9:24496810-24496811	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs534096407	chr9:24496904-24496905	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs79022543	chr9:24496920-24496921	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs397733045	chr9:24496921-24496922	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs562971498	chr9:24496988-24496989	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs147992088	chr9:24497027-24497028	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs551904740	chr9:24497036-24497037	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs564961678	chr9:24497046-24497047	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs527466604	chr9:24497052-24497053	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs547391075	chr9:24497083-24497084	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs375167471	chr9:24497122-24497123	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs112409332	chr9:24497126-24497127	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs113075152	chr9:24497167-24497168	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs535847556	chr9:24497169-24497170	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs549324679	chr9:24497210-24497211	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs569299585	chr9:24497218-24497219	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs575440383	chr9:24497219-24497220	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs372421098	chr9:24497223-24497224	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs538392180	chr9:24497228-24497229	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:148)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Myelofibrosis	22110671	CNVD
Ewing''s sarcoma	22429812	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	19435819	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Lung cancer	21911935	CNVD
Primary central nervous system lymphoma	21088137	CNVD
head and neck squamous cell carcinoma	21798897	CNVD
Cancer	21253487	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Glioblastoma multiforme	21922591	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Urothelial cell carcinoma	18451213	CNVD
Glioma	17123091	CNVD
Mental retardation	17124404	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Leukemia	19602459	CNVD
Acute monocytic leukemia	16498392	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Leukemia	18688285	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Melanoma	17363583	CNVD
Glioblastoma multiforme	19115005	CNVD
Adenoid cystic carcinoma	18332873	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Esophageal adenocarcinoma	18519675	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Renal cell carcinoma	21215367	CNVD
Breast cancer	22522925	CNVD
Lung cancer	21569311	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:198 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:24487800-24496000	Weak transcription	H1 Cell Line	embryonic stem cell
2	chr9:24489400-24496000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr9:24490200-24496400	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr9:24490400-24495800	Weak transcription	HUES64 Cell Line	embryonic stem cell
5	chr9:24490600-24495800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
6	chr9:24495000-24502200	Enhancers	iPS-18 Cell Line	embryonic stem cell
7	chr9:24495200-24498800	Enhancers	iPS-20b Cell Line	embryonic stem cell
8	chr9:24495400-24497600	Enhancers	HUES48 Cell Line	embryonic stem cell
9	chr9:24495600-24498800	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr9:24495800-24496600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr9:24495800-24504200	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr9:24496000-24496600	Enhancers	H1 Cell Line	embryonic stem cell
13	chr9:24496000-24501000	Enhancers	ES-I3 Cell Line	embryonic stem cell
14	chr9:24496400-24497600	Enhancers	H9 Cell Line	embryonic stem cell
15	chr9:24496400-24498800	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr9:24496600-24497000	Weak transcription	H1 Cell Line	embryonic stem cell
17	chr9:24496600-24498600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr9:24497000-24497200	Enhancers	H1 Cell Line	embryonic stem cell
19	chr9:24497000-24497200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr9:24497000-24499400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr9:24497200-24502400	Weak transcription	H1 Cell Line	embryonic stem cell
22	chr9:24497600-24498000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
23	chr9:24497600-24502600	Weak transcription	H9 Cell Line	embryonic stem cell
24	chr9:24497800-24499400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr9:24498000-24498400	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr9:24498000-24502600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr9:24498200-24499400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
28	chr9:24498400-24498600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
29	chr9:24498600-24498800	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr9:24498600-24499800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr9:24498800-24499000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
32	chr9:24498800-24499000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
33	chr9:24498800-24499200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
34	chr9:24498800-24499800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
35	chr9:24499000-24499200	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr9:24499000-24503400	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr9:24499200-24499400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
38	chr9:24499200-24499600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
39	chr9:24499200-24501200	Enhancers	iPS-15b Cell Line	embryonic stem cell
40	chr9:24499400-24499600	Enhancers	HUES6 Cell Line	embryonic stem cell
41	chr9:24499400-24502000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr9:24499400-24502200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr9:24499400-24502400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr9:24499600-24500600	Weak transcription	HUES6 Cell Line	embryonic stem cell
45	chr9:24499600-24500800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
46	chr9:24499800-24500000	Enhancers	iPS-20b Cell Line	embryonic stem cell
47	chr9:24499800-24501400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
48	chr9:24500000-24502000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
49	chr9:24500600-24501800	Enhancers	HUES6 Cell Line	embryonic stem cell
50	chr9:24500800-24501200	Enhancers	ES-WA7 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links